| Sara Lanea Bowman, MS, CF-SLP | |
|
110 Mannon Dr, Alum Creek, WV 25003-9566 | |
| (304) 923-8833 | |
| Not Available |
| Full Name | Sara Lanea Bowman |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 110 Mannon Dr, Alum Creek, West Virginia |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1417621863 | NPI | - | NPPES |
| 0908 | Medicaid | WV |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 0908 (West Virginia) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Sara Lanea Bowman, MS, CF-SLP 110 Mannon Dr, Alum Creek, WV 25003-9566 Ph: (304) 923-8833 | Sara Lanea Bowman, MS, CF-SLP 110 Mannon Dr, Alum Creek, WV 25003-9566 Ph: (304) 923-8833 |
News Archive
Just one in ten parents and young people aged 14-18 are aware that teenagers are among the most at-risk for contracting meningitis, according to new research from GSK.
The culprit behind mad cow disease, a.k.a. bovine spongiform encephalopathy, is the most infamous mammalian form of prions. Prions are misfolded proteins that are capable of growing, replicating, and being passed on to daughter cells, that is, they are by themselves heritable. Beyond their disease manifestation, prions also occur naturally in some organisms (such as yeast) and may play important roles in their growth and development. Now, Osherovich and colleagues have identified the amino acid sequences that allow prions to aggregate and replicate, and thereby pass through generations of cells - and prove this by designing an artificial yeast prion that does not exist in nature.
On the eve of World Cancer Day, University of South Australia researchers are calling for more support for cancer survivors, who often feel the physical and mental impacts of their disease long after treatment has finished.
Total revenues were $37.5 million and included recognition of a $5.0 million milestone payment from Mallinckrodt related to the NDA filing of MNK-795. Excluding this milestone and a $10 million upfront payment from Janssen in the third quarter of 2012, total revenues of $32.5 million grew 39% compared to $23.3 million for the third quarter of 2012.
› Verified 8 days ago